These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Marijuana's effects on human cognitive functions, psychomotor functions, and personality. Murray JB J Gen Psychol; 1986 Jan; 113(1):23-55. PubMed ID: 3009708 [TBL] [Abstract][Full Text] [Related]
10. A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder. Velit-Salazar MR; Shiroma PR; Cherian E Brain Sci; 2024 Mar; 14(3):. PubMed ID: 38539636 [TBL] [Abstract][Full Text] [Related]
11. Can inhaled cannabis users accurately evaluate impaired driving ability? A randomized controlled trial. Hartley S; Simon N; Cardozo B; Larabi IA; Alvarez JC Front Public Health; 2023; 11():1234765. PubMed ID: 38074719 [TBL] [Abstract][Full Text] [Related]
12. Regular cannabis use alters the neural dynamics serving complex motor control. Ward TW; Springer SD; Schantell M; John JA; Horne LK; Coutant AT; Okelberry HJ; Willett MP; Johnson HJ; Killanin AD; Heinrichs-Graham E; Wilson TW Hum Brain Mapp; 2023 Dec; 44(18):6511-6522. PubMed ID: 37955378 [TBL] [Abstract][Full Text] [Related]
13. Regular cannabis use modulates the impact of HIV on the neural dynamics serving cognitive control. Schantell M; Springer SD; Arif Y; Sandal ME; Willett MP; Johnson HJ; Okelberry HJ; O'Neill JL; May PE; Bares SH; Wilson TW J Psychopharmacol; 2022 Dec; 36(12):1324-1337. PubMed ID: 36416285 [TBL] [Abstract][Full Text] [Related]
14. Changes in Cannabis Consumption During the Global COVID-19 Lockdown: The International COVISTRESS Study. Salles J; Yrondi A; Marhar F; Andant N; Dorlhiac RA; Quach B; Jiao J; Antunes S; Ugbolue UC; Guegan J; Rouffiac K; Pereira B; ; Clinchamps M; Dutheil F Front Psychiatry; 2021; 12():689634. PubMed ID: 34858218 [No Abstract] [Full Text] [Related]
15. Cannabis, Impaired Driving, and Road Safety: An Overview of Key Questions and Issues. Brands B; Di Ciano P; Mann RE Front Psychiatry; 2021; 12():641549. PubMed ID: 34489746 [TBL] [Abstract][Full Text] [Related]
16. Cannabinoid receptor type 1 antagonists alter aspects of risk/reward decision making independent of toluene-mediated effects. Braunscheidel KM; Okas MP; Floresco SB; Woodward JJ Psychopharmacology (Berl); 2022 May; 239(5):1337-1347. PubMed ID: 34291308 [TBL] [Abstract][Full Text] [Related]
17. Differential Cognitive Performance in Females and Males with Regular Cannabis Use. Schnakenberg Martin AM; D'Souza DC; Newman SD; Hetrick WP; O'Donnell BF J Int Neuropsychol Soc; 2021 Jul; 27(6):570-580. PubMed ID: 34261548 [TBL] [Abstract][Full Text] [Related]